Great Lakes Advisors LLC Trims Position in Colgate-Palmolive (NYSE:CL)

Great Lakes Advisors LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.4% during the fourth quarter, HoldingsChannel reports. The firm owned 108,063 shares of the company’s stock after selling 428 shares during the period. Great Lakes Advisors LLC’s holdings in Colgate-Palmolive were worth $9,824,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $26,000. Centricity Wealth Management LLC purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $32,000. Briaud Financial Planning Inc purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $32,000. Finally, OFI Invest Asset Management purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

CL opened at $90.71 on Thursday. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $73.61 billion, a PE ratio of 25.77, a P/E/G ratio of 4.20 and a beta of 0.40. The firm has a 50 day moving average of $89.03 and a two-hundred day moving average of $94.96.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the firm posted $0.87 earnings per share. On average, analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Barclays lowered their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. UBS Group lowered their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Raymond James restated an “outperform” rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $101.61.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.